McDonald’s Corp. has finally updated its antibiotics policy that calls for reduced antibiotic usage after a two-year delay.
The fast-food giant’s new policy revealed in Decemebr follows guidelines set out by the World Health Organization (WHO), the World Organization for Animal Health, and other public and animal health groups.
According to McDonald’s, they will focus on the responsible use of medically important antibiotics and be aligned with WHO Guidelines on Antimicrobial Resistance.
The company added that its policy does not permit the routine use of medically important antibiotics for growth promotion or tdisease prevention.
It is committed to usage reduction, where possible without adverse effects on animal health and welfare.
The company has established market-specific targets for the responsible use of antibiotics for 10 in-scope markets, representing over 80 percent of its global beef supply chain.
In 2023, McDonald’s plans to share an update on its antibiotic usage.
However, the Natural Resources Defense Council (NRDC) criticized McDonald’s for failing to detail a rollout plan or a completion date to ensure accountability across the supply chain.
According to Lena Brook, director of food campaigns at NRDC, it is especially disappointing given that McDonald’s, the world’s largest beef buyer, chose optics over substance with its new beef policy update despite the urgency of the global antibiotic resistance crisis.
McDonald’s earned a grade of C from the NDRC for its previous policy. NDRC called McDonald’s updated policy a “new, weaker approach.”


Global Flight Cancellations 2026: Middle East Air Travel Chaos Explained
Oil Prices Plunge Over 6% as Middle East Ceasefire Hopes Ease Supply Fears
Intermittent fasting doesn’t have an edge for weight loss, but might still work for some
Delivery Hero Sells Taiwan Foodpanda to Grab for $600 Million in Debt-Reduction Push
Nanya Technology Shares Surge 10% After $2.5 Billion Private Placement from Sandisk and Cisco
Merck's $6 Billion Bid for Terns Pharma Signals Bold Oncology Push
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
Sonova Shares Slip as Hearing Aid Giant Lowers Growth Outlook and Plans Sennheiser Exit
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Time to buy local: war fuel price shocks reveal the folly of a long food supply chain
Brown-Forman and Pernod Ricard in Merger Talks to Create World's Largest Spirits Giant
Citi Names Eric Farina and Rob Cascarino to Lead Global Infrastructure Financing Group
Nintendo Switch 2 Production Cut as Holiday Sales Miss Targets
OpenAI Pulls the Plug on Sora, Ending $1 Billion Disney Partnership
Australia's Inflation Eases in February but Core Pressures Persist 



